Concepts (309)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patellofemoral Joint | 6 | 2020 | 133 | 2.820 |
Why?
|
Osteoarthritis, Knee | 11 | 2022 | 1251 | 2.500 |
Why?
|
Social Isolation | 14 | 2020 | 366 | 2.090 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 8 | 2018 | 903 | 1.690 |
Why?
|
Swimming | 14 | 2018 | 209 | 1.330 |
Why?
|
Antidepressive Agents | 12 | 2017 | 2913 | 1.250 |
Why?
|
Stress, Psychological | 16 | 2020 | 4529 | 1.040 |
Why?
|
Hindlimb Suspension | 3 | 2016 | 76 | 1.020 |
Why?
|
Patella | 4 | 2020 | 317 | 0.970 |
Why?
|
Osteophyte | 3 | 2019 | 44 | 0.960 |
Why?
|
Nitric Oxide | 11 | 2018 | 2146 | 0.910 |
Why?
|
Depression | 16 | 2018 | 8231 | 0.880 |
Why?
|
Cartilage, Articular | 3 | 2020 | 1104 | 0.870 |
Why?
|
Receptors, Opioid | 4 | 2016 | 145 | 0.860 |
Why?
|
Indoles | 6 | 2017 | 1835 | 0.810 |
Why?
|
Hand Joints | 2 | 2022 | 58 | 0.810 |
Why?
|
Narcotic Antagonists | 4 | 2018 | 591 | 0.750 |
Why?
|
Behavior, Animal | 13 | 2017 | 1861 | 0.740 |
Why?
|
Ulnar Neuropathies | 1 | 2020 | 32 | 0.710 |
Why?
|
Fractures, Closed | 1 | 2020 | 88 | 0.670 |
Why?
|
Exostoses | 1 | 2019 | 30 | 0.670 |
Why?
|
Osteoarthritis | 3 | 2022 | 1072 | 0.660 |
Why?
|
Hippocampus | 12 | 2020 | 3786 | 0.640 |
Why?
|
Magnetic Resonance Imaging | 14 | 2024 | 36743 | 0.610 |
Why?
|
Ondansetron | 2 | 2016 | 95 | 0.610 |
Why?
|
Tibia | 3 | 2019 | 1075 | 0.610 |
Why?
|
Cyclic GMP | 2 | 2016 | 394 | 0.590 |
Why?
|
Ankle Joint | 1 | 2022 | 452 | 0.590 |
Why?
|
Naltrexone | 6 | 2018 | 319 | 0.580 |
Why?
|
Pancreatitis, Chronic | 1 | 2020 | 282 | 0.560 |
Why?
|
Seizures | 10 | 2019 | 2998 | 0.540 |
Why?
|
Maternal Deprivation | 4 | 2017 | 40 | 0.530 |
Why?
|
Patellar Dislocation | 1 | 2017 | 67 | 0.530 |
Why?
|
Anti-Anxiety Agents | 2 | 2015 | 405 | 0.520 |
Why?
|
Serotonin Antagonists | 1 | 2016 | 147 | 0.500 |
Why?
|
Nitric Oxide Synthase | 4 | 2018 | 911 | 0.490 |
Why?
|
Anxiety | 6 | 2018 | 4672 | 0.490 |
Why?
|
Nitrites | 6 | 2018 | 156 | 0.470 |
Why?
|
Nitrates | 1 | 2016 | 260 | 0.470 |
Why?
|
Encephalitis | 2 | 2018 | 441 | 0.470 |
Why?
|
Lithium Compounds | 1 | 2015 | 226 | 0.450 |
Why?
|
Edema | 1 | 2018 | 765 | 0.450 |
Why?
|
Pentylenetetrazole | 7 | 2018 | 72 | 0.440 |
Why?
|
Pancreatitis | 1 | 2020 | 1087 | 0.420 |
Why?
|
Bone Marrow | 3 | 2022 | 2935 | 0.420 |
Why?
|
Fluoxetine | 2 | 2016 | 733 | 0.410 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2016 | 491 | 0.410 |
Why?
|
Diagnostic Errors | 1 | 2020 | 1280 | 0.400 |
Why?
|
Hip Fractures | 1 | 2020 | 997 | 0.390 |
Why?
|
Radiology | 3 | 2022 | 2104 | 0.380 |
Why?
|
Serotonin 5-HT3 Receptor Antagonists | 3 | 2016 | 23 | 0.380 |
Why?
|
Nicotine | 1 | 2015 | 680 | 0.350 |
Why?
|
Morphine | 6 | 2016 | 658 | 0.340 |
Why?
|
Dizocilpine Maleate | 5 | 2018 | 171 | 0.340 |
Why?
|
Cholestasis | 1 | 2013 | 385 | 0.340 |
Why?
|
Convulsants | 4 | 2018 | 70 | 0.340 |
Why?
|
Joint Instability | 1 | 2017 | 803 | 0.330 |
Why?
|
Four-Dimensional Computed Tomography | 2 | 2022 | 142 | 0.330 |
Why?
|
Disease Management | 1 | 2020 | 2533 | 0.320 |
Why?
|
Cartilage Diseases | 2 | 2022 | 160 | 0.320 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1759 | 0.310 |
Why?
|
Bone and Bones | 1 | 2019 | 2589 | 0.300 |
Why?
|
Anticonvulsants | 5 | 2019 | 1922 | 0.300 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3251 | 0.300 |
Why?
|
Oxidative Stress | 2 | 2016 | 3140 | 0.300 |
Why?
|
Mice | 36 | 2020 | 82024 | 0.290 |
Why?
|
Mitochondria | 6 | 2019 | 3681 | 0.290 |
Why?
|
Anxiety Disorders | 2 | 2015 | 2748 | 0.280 |
Why?
|
Dose-Response Relationship, Drug | 11 | 2019 | 10757 | 0.280 |
Why?
|
Male | 53 | 2024 | 364638 | 0.270 |
Why?
|
Cartilage | 2 | 2020 | 811 | 0.270 |
Why?
|
Electroshock | 2 | 2018 | 120 | 0.270 |
Why?
|
NG-Nitroarginine Methyl Ester | 3 | 2016 | 262 | 0.260 |
Why?
|
Adipose Tissue | 1 | 2018 | 3329 | 0.260 |
Why?
|
Knee Joint | 5 | 2022 | 1683 | 0.260 |
Why?
|
Amphetamine | 2 | 2018 | 222 | 0.260 |
Why?
|
Receptors, Opioid, mu | 2 | 2018 | 171 | 0.250 |
Why?
|
Motor Activity | 5 | 2016 | 2711 | 0.250 |
Why?
|
Cyclohexanecarboxylic Acids | 2 | 2017 | 139 | 0.250 |
Why?
|
Receptor, Cannabinoid, CB1 | 2 | 2017 | 137 | 0.250 |
Why?
|
Enzyme Inhibitors | 8 | 2018 | 3726 | 0.250 |
Why?
|
Disease Progression | 8 | 2022 | 13667 | 0.240 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2016 | 451 | 0.240 |
Why?
|
Crohn Disease | 1 | 2017 | 2295 | 0.240 |
Why?
|
Animals | 42 | 2020 | 169225 | 0.240 |
Why?
|
Amines | 2 | 2017 | 280 | 0.240 |
Why?
|
Prostatic Neoplasms | 2 | 2024 | 11101 | 0.230 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4362 | 0.230 |
Why?
|
Depressive Disorder | 2 | 2016 | 3721 | 0.220 |
Why?
|
Exploratory Behavior | 4 | 2018 | 273 | 0.210 |
Why?
|
Oxytocin | 2 | 2017 | 403 | 0.210 |
Why?
|
Serotonin | 3 | 2016 | 1043 | 0.200 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2018 | 628 | 0.200 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5447 | 0.190 |
Why?
|
Pruritus | 2 | 2015 | 378 | 0.190 |
Why?
|
Disease Models, Animal | 16 | 2018 | 18345 | 0.190 |
Why?
|
Radiography | 4 | 2022 | 6981 | 0.190 |
Why?
|
Collateral Ligaments | 1 | 2021 | 34 | 0.180 |
Why?
|
Elbow | 1 | 2020 | 130 | 0.170 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2017 | 1140 | 0.170 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5814 | 0.170 |
Why?
|
Locomotion | 3 | 2018 | 388 | 0.170 |
Why?
|
Humans | 36 | 2024 | 767998 | 0.160 |
Why?
|
Rheumatic Nodule | 1 | 2018 | 2 | 0.160 |
Why?
|
Quality-Adjusted Life Years | 3 | 2020 | 1741 | 0.160 |
Why?
|
Receptors, Opioid, delta | 1 | 2018 | 48 | 0.160 |
Why?
|
Internship and Residency | 1 | 2019 | 5953 | 0.160 |
Why?
|
Central Nervous System Stimulants | 2 | 2018 | 1168 | 0.150 |
Why?
|
Reactive Oxygen Species | 2 | 2016 | 2149 | 0.150 |
Why?
|
Receptors, Opioid, kappa | 1 | 2018 | 136 | 0.140 |
Why?
|
Prostate-Specific Antigen | 2 | 2024 | 2463 | 0.140 |
Why?
|
Child Mortality | 1 | 2019 | 204 | 0.140 |
Why?
|
Silver | 1 | 2018 | 118 | 0.140 |
Why?
|
Wrist Joint | 1 | 2019 | 267 | 0.140 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2017 | 48 | 0.140 |
Why?
|
Benzenesulfonates | 1 | 2017 | 170 | 0.140 |
Why?
|
Minocycline | 1 | 2018 | 170 | 0.140 |
Why?
|
Nitrosation | 1 | 2016 | 25 | 0.130 |
Why?
|
Selegiline | 1 | 2016 | 31 | 0.130 |
Why?
|
Drug Inverse Agonism | 1 | 2016 | 11 | 0.130 |
Why?
|
Animals, Newborn | 3 | 2016 | 2678 | 0.130 |
Why?
|
Receptors, Histamine H3 | 1 | 2015 | 11 | 0.130 |
Why?
|
Receptors, Histamine H1 | 1 | 2015 | 20 | 0.130 |
Why?
|
Potassium Channels | 1 | 2019 | 538 | 0.130 |
Why?
|
Patients | 1 | 2022 | 908 | 0.130 |
Why?
|
Lithium Chloride | 1 | 2016 | 83 | 0.130 |
Why?
|
Endorphins | 1 | 2015 | 73 | 0.130 |
Why?
|
Evaluation Studies as Topic | 1 | 2018 | 1625 | 0.130 |
Why?
|
Prostate | 1 | 2024 | 1765 | 0.130 |
Why?
|
Anxiety, Separation | 1 | 2015 | 85 | 0.130 |
Why?
|
Rubidium | 1 | 2015 | 121 | 0.130 |
Why?
|
Antipruritics | 1 | 2015 | 31 | 0.120 |
Why?
|
Biopsy | 2 | 2024 | 6786 | 0.120 |
Why?
|
Propensity Score | 2 | 2022 | 1970 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20757 | 0.120 |
Why?
|
Cytotoxins | 1 | 2016 | 154 | 0.120 |
Why?
|
Receptors, Serotonin, 5-HT3 | 1 | 2015 | 45 | 0.120 |
Why?
|
Capsaicin | 1 | 2016 | 233 | 0.120 |
Why?
|
Immunity, Innate | 2 | 2018 | 3079 | 0.120 |
Why?
|
Sympathectomy | 1 | 2015 | 72 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 1 | 2020 | 398 | 0.120 |
Why?
|
Nitrogen Oxides | 1 | 2015 | 128 | 0.120 |
Why?
|
Corticosterone | 1 | 2015 | 301 | 0.120 |
Why?
|
Arginine | 2 | 2018 | 932 | 0.120 |
Why?
|
Receptors, Dopamine D1 | 1 | 2016 | 277 | 0.120 |
Why?
|
Infant Mortality | 1 | 2019 | 752 | 0.120 |
Why?
|
Motivation | 4 | 2018 | 2020 | 0.120 |
Why?
|
Immobilization | 1 | 2015 | 229 | 0.120 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 937 | 0.110 |
Why?
|
Female | 19 | 2022 | 397102 | 0.110 |
Why?
|
Oxides | 1 | 2016 | 403 | 0.110 |
Why?
|
Toll-Like Receptors | 1 | 2017 | 582 | 0.110 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26377 | 0.110 |
Why?
|
Middle Aged | 12 | 2024 | 223422 | 0.110 |
Why?
|
Receptors, Dopamine D2 | 1 | 2016 | 471 | 0.110 |
Why?
|
Piperidines | 3 | 2018 | 1667 | 0.110 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 406 | 0.110 |
Why?
|
N-Methylaspartate | 1 | 2014 | 231 | 0.110 |
Why?
|
Renal Artery | 1 | 2015 | 355 | 0.110 |
Why?
|
Lithium | 1 | 2016 | 600 | 0.110 |
Why?
|
Disabled Persons | 2 | 2020 | 1210 | 0.110 |
Why?
|
Patient Satisfaction | 2 | 2022 | 3488 | 0.110 |
Why?
|
Mitochondrial Diseases | 1 | 2017 | 344 | 0.110 |
Why?
|
Embryonic Stem Cells | 1 | 2020 | 1250 | 0.110 |
Why?
|
Interleukin-1beta | 2 | 2016 | 1027 | 0.100 |
Why?
|
Physical Examination | 1 | 2019 | 1263 | 0.100 |
Why?
|
Pain Threshold | 1 | 2016 | 607 | 0.100 |
Why?
|
Femur | 1 | 2019 | 1321 | 0.100 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14785 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2004 | 0.100 |
Why?
|
Chlorides | 1 | 2015 | 666 | 0.100 |
Why?
|
Pituitary-Adrenal System | 1 | 2015 | 555 | 0.100 |
Why?
|
PPAR gamma | 1 | 2015 | 485 | 0.100 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2017 | 2442 | 0.100 |
Why?
|
Ligation | 1 | 2013 | 446 | 0.100 |
Why?
|
Pyrazoles | 3 | 2018 | 2028 | 0.100 |
Why?
|
Bile Ducts | 1 | 2013 | 288 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1892 | 0.090 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2015 | 703 | 0.090 |
Why?
|
Artifacts | 1 | 2020 | 1923 | 0.090 |
Why?
|
Headache | 1 | 2019 | 1262 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3628 | 0.090 |
Why?
|
Maternal Exposure | 1 | 2018 | 1096 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2019 | 5314 | 0.090 |
Why?
|
Ultrasonography | 2 | 2021 | 6004 | 0.090 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15944 | 0.090 |
Why?
|
Foot | 1 | 2014 | 576 | 0.080 |
Why?
|
Analgesics, Opioid | 5 | 2018 | 3840 | 0.080 |
Why?
|
Aged | 7 | 2024 | 171453 | 0.080 |
Why?
|
Mood Disorders | 1 | 2016 | 1129 | 0.080 |
Why?
|
Colitis | 1 | 2017 | 1240 | 0.080 |
Why?
|
Ethanol | 1 | 2015 | 1331 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2521 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2016 | 1409 | 0.080 |
Why?
|
Prognosis | 2 | 2020 | 29984 | 0.070 |
Why?
|
Colon | 1 | 2016 | 1800 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2015 | 1130 | 0.070 |
Why?
|
Fractures, Bone | 1 | 2020 | 2062 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 13000 | 0.070 |
Why?
|
Inflammation | 2 | 2017 | 10872 | 0.070 |
Why?
|
Vasotocin | 2 | 2017 | 10 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2515 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2016 | 1681 | 0.070 |
Why?
|
Internet | 1 | 2019 | 3111 | 0.070 |
Why?
|
Hormone Antagonists | 2 | 2017 | 108 | 0.070 |
Why?
|
Decision Making | 1 | 2020 | 3953 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2019 | 1713 | 0.060 |
Why?
|
Nitric Oxide Synthase Type I | 2 | 2016 | 175 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2538 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2666 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14718 | 0.060 |
Why?
|
Maze Learning | 2 | 2017 | 482 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2540 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4598 | 0.060 |
Why?
|
Time Factors | 4 | 2018 | 40210 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2016 | 2058 | 0.050 |
Why?
|
Signal Transduction | 4 | 2018 | 23640 | 0.050 |
Why?
|
Pain | 1 | 2016 | 5100 | 0.050 |
Why?
|
Brain | 3 | 2018 | 27366 | 0.050 |
Why?
|
Metacarpophalangeal Joint | 1 | 2021 | 82 | 0.040 |
Why?
|
Ontario | 1 | 2021 | 403 | 0.040 |
Why?
|
Risk Factors | 3 | 2024 | 74938 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7067 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2024 | 81748 | 0.040 |
Why?
|
Disease Susceptibility | 2 | 2017 | 1793 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7940 | 0.040 |
Why?
|
United Nations | 1 | 2019 | 151 | 0.040 |
Why?
|
Thumb | 1 | 2021 | 232 | 0.040 |
Why?
|
Receptors, Cannabinoid | 1 | 2018 | 43 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9493 | 0.040 |
Why?
|
Computer Systems | 1 | 2020 | 469 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2018 | 6225 | 0.040 |
Why?
|
State Medicine | 1 | 2020 | 219 | 0.040 |
Why?
|
Quality of Life | 1 | 2020 | 13489 | 0.040 |
Why?
|
Body Weight | 2 | 2021 | 4628 | 0.040 |
Why?
|
Finger Joint | 1 | 2018 | 108 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2019 | 426 | 0.040 |
Why?
|
Geography | 1 | 2019 | 652 | 0.040 |
Why?
|
Incidence | 3 | 2020 | 21533 | 0.030 |
Why?
|
Streptozocin | 1 | 2016 | 190 | 0.030 |
Why?
|
Phospholipases A2 | 1 | 2016 | 197 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39340 | 0.030 |
Why?
|
Immobility Response, Tonic | 1 | 2016 | 13 | 0.030 |
Why?
|
Grooming | 1 | 2016 | 38 | 0.030 |
Why?
|
Histamine Agonists | 1 | 2015 | 13 | 0.030 |
Why?
|
Naphthalenes | 1 | 2017 | 198 | 0.030 |
Why?
|
Nitric Oxide Donors | 1 | 2016 | 126 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15662 | 0.030 |
Why?
|
Brazil | 1 | 2020 | 1250 | 0.030 |
Why?
|
Arsenicals | 1 | 2016 | 117 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2020 | 533 | 0.030 |
Why?
|
Histamine Antagonists | 1 | 2015 | 94 | 0.030 |
Why?
|
Dopamine Agents | 1 | 2016 | 188 | 0.030 |
Why?
|
Benzoxazines | 1 | 2017 | 320 | 0.030 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2016 | 103 | 0.030 |
Why?
|
Guanylate Cyclase | 1 | 2016 | 206 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59600 | 0.030 |
Why?
|
TRPV Cation Channels | 1 | 2016 | 244 | 0.030 |
Why?
|
Random Allocation | 1 | 2019 | 2396 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2130 | 0.030 |
Why?
|
Indazoles | 1 | 2016 | 306 | 0.030 |
Why?
|
Restraint, Physical | 1 | 2015 | 184 | 0.030 |
Why?
|
Morpholines | 1 | 2017 | 584 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2016 | 598 | 0.030 |
Why?
|
Cytosol | 1 | 2016 | 887 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1854 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3438 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2618 | 0.030 |
Why?
|
Life Expectancy | 1 | 2020 | 1248 | 0.030 |
Why?
|
Food Preferences | 1 | 2016 | 397 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 589 | 0.030 |
Why?
|
Sheep | 1 | 2015 | 1449 | 0.030 |
Why?
|
Age Factors | 2 | 2022 | 18405 | 0.020 |
Why?
|
Aggression | 1 | 2017 | 749 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2016 | 1888 | 0.020 |
Why?
|
Housing | 1 | 2017 | 683 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 958 | 0.020 |
Why?
|
beta Catenin | 1 | 2016 | 1047 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22369 | 0.020 |
Why?
|
Adult | 3 | 2019 | 223577 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2854 | 0.020 |
Why?
|
Ketamine | 1 | 2016 | 527 | 0.020 |
Why?
|
Self Care | 1 | 2015 | 799 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2121 | 0.020 |
Why?
|
Sex Factors | 1 | 2022 | 10629 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15443 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6232 | 0.020 |
Why?
|
Public Health | 1 | 2019 | 2682 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7851 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3585 | 0.020 |
Why?
|
Pregnancy | 2 | 2018 | 30244 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4351 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10471 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12536 | 0.010 |
Why?
|
Heart | 1 | 2016 | 4445 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15867 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24317 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4884 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10590 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15597 | 0.010 |
Why?
|
Skin | 1 | 2015 | 4502 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 89154 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12797 | 0.010 |
Why?
|
Rats | 1 | 2016 | 23751 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26418 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36533 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 60050 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65360 | 0.010 |
Why?
|
Child | 1 | 2019 | 80905 | 0.010 |
Why?
|
Concepts
(309)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_